Food Standards Agency updated guidance in CBD businesses

Ever wondered if the CBD products on your shelves are truly safe—or if they might unknowingly exceed legal limits?

The UK’s Food Standards Agency (FSA) has just updated its guidance, giving businesses a golden opportunity to reformulate their existing CBD products for safety reasons. With the surge in consumer demand for CBD-infused foods and supplements, staying compliant has never been more critical. The FSA now highlights a provisional Acceptable Daily Intake (ADI) of 10 mg of CBD per day, roughly 0.15 mg per kg of body weight for an average adult, alongside a strict THC limit of 0.07 mg per day. These thresholds are designed to safeguard consumers while allowing companies flexibility in reformulating their products. For businesses with products already listed on the FSA’s Public List, this is an ideal moment to review formulations, reduce THC levels, and ensure CBD doses remain within safe limits. Using high-quality ingredients like CBD Powder by IngredientPharm, renowned for its ultra-low THC content, can make reformulation easier, guaranteeing compliance without compromising on efficiency. In short, the latest guidance isn’t just a regulatory update—it’s an opportunity to create safer, more trustworthy CBD products that build consumer confidence while meeting stringent safety standards.

Quick Summary Table

Aspect	Details
CBD ADI	10 mg/day (≈ 0.15 mg/kg for a 70 kg adult)
THC Safe Upper Limit	0.07 mg/day (≈ 1 µg/kg for a 70 kg adult)
Body Weight Consideration	Limits are standardized to 70 kg, but imply mg/kg scaling
Reformulation Policy	Allowed for products on Public List—must submit updates if details change
Product Registration	Must include application number and confirm safety-driven changes
Benefit of IngredientPharm CBD Powder	Lowest THC aids compliance, simplifies reformulation without losing CBD potency

Advantage of using CBD Powder by ingredientpharm for reformulated products

Following food manufacture journal, more than 12,000 CBD products to consider reformulation (link). While not mentioned in the FSA’s official release, using CBD Powder by ingredientpharm for reformulation could offer key advantages due to its notably low THC content. Here’s how that aligns with the new guidance:

• Since the FSA sets the THC limit at 0.07 mg/day, using a CBD ingredient with very low THC levels ensures you’re more likely to meet or stay well below this threshold.

• This simplifies compliance efforts—especially when reducing THC as part of reformulation—and helps avoid potential Controlled Drugs Licence (CDL) concerns or breaches of the Misuse of Drugs Act 1971.

• Additionally, a low-THC powder supports maintaining the desired CBD potency (within the 10 mg/day ADI) without risking THC overages.

You need guidance in CBD businesses, formulation information, or trustful CBD intermediate for your urging reformulation tasks? Get in touch with our team and find the right product solution easily.